Upcoming Reports [full schedule to be confirmed]
Schedule of Publications 2022
2023
Oct
Environmental, Social & Governance Report
New Survey 2023
Sep
Arthritis Edition
Corporate Reputation of Pharma 2022
Mental Health Edition
Corporate Reputation of Pharma 2022
Respiratory Edition
Corporate Reputation of Pharma 2022
Aug
Spain Edition
Corporate Reputation of Pharma 2022
Rare Diseases Edition [with Bleeding Disorders]
Corporate Reputation of Pharma 2022
Jul
Australia, New Zealand, China and Japan Edition
Corporate Reputation of Pharma 2022
Neurological Edition [with Multiple Sclerosis]
Corporate Reputation of Pharma 2022
France Edition
Corporate Reputation of Pharma 2022
Jun
Italy Edition
Corporate Reputation of Pharma 2022
Germany Edition
Corporate Reputation of Pharma 2022
Cancer Edition
Corporate Reputation of Pharma 2022
Ukraine Report
New Survey 2023
Published
May
Canada Edition
Corporate Reputation of Pharma 2022
Published
UK Edition
Corporate Reputation of Pharma 2022
Published
USA Edition
Corporate Reputation of Pharma 2022
Published
Apr
Global Edition
Corporate Reputation of Pharma 2022
Published
2022
Nov
Mental Health Edition
Corporate Reputation of Pharma 2021
Published
Neurological Edition
Corporate Reputation of Pharma 2021
Published
Oct
Autoimmune Edition
Corporate Reputation of Pharma 2021
Published
Respiratory Edition
Corporate Reputation of Pharma 2021
Published
Sep
Rare Diseases Edition (with Bleeding Disorders subanalyses)
Corporate Reputation of Pharma 2021
Published
Italy Edition
Corporate Reputation of Pharma 2021
Published
Spain Edition
Corporate Reputation of Pharma 2021
Published
Aug
Asia Edition
Corporate Reputation of Pharma 2021
Published
Germany Edition
Corporate Reputation of Pharma 2021
Published
Jul
UK Edition
Corporate Reputation of Pharma 2021
Published
France Edition
Corporate Reputation of Pharma 2021
Published
Jun
ESG report
Corporate Reputation of Pharma 2021
Published
Canada Edition
Corporate Reputation of Pharma 2021
Published
HIV/AIDS Edition
Corporate Reputation of Pharma 2021
Published
May
MAIN Cancer [including subanalyses]
Cancer Edition, Corporate Reputation of Pharma 2021
Published
USA Edition
Corporate Reputation of Pharma 2021
Published
Apr
Global Edition
Corporate Reputation of Pharma 2021
Published